Sanofi To Test Arthritis Drug Kevzara For Coronavirus
'Scientific Rationale' Behind Regeneron-partnered IL-6 Inhibitor
The French giant is already working on a vaccine to combat COVID-19 and is now evaluating whether its rheumatoid arthritis drug Kevzara could treat pulmonary complications related to the coronavirus.
